Related content

Vaccination of patients with advanced ovarian carcinoma with the anti-idiotype ACA125: immunological response and survival (phase Ib/II)

By  

The Women's Oncology Review, Vol. 4, Iss. 2, 2004-06 ,pp. : 129-130

Informa Healthcare

Access to resources Recommend Favorite

Multiple myeloma emerging after chemotherapy for non-small-cell lung cancer

By Marinopoulos Spyridon   Skorda Lamprini   Karatapanis Stylianos   Rasidakis Antonis  

Medical Oncology, Vol. 25, Iss. 4, 2008-12 ,pp. : 415-418

Humana Press, Inc

Access to resources Recommend Favorite

Pegylated Liposomal Doxorubicin in Salvage Chemotherapy for Multiple Myeloma Patients

By  

Current Cancer Therapy Reviews, Vol. 9, Iss. 1, 2013-01 ,pp. : 1-7

Bentham Science Publishers

Access to resources Recommend Favorite

Idiotype Immunity (Natural and Vaccine-induced) in Early Stage Multiple Myeloma

By Österborg Anders   Henriksson Lotta   Mellstedt Håkan  

Acta Oncologica, Vol. 39, Iss. 7, 2000-11 ,pp. : 797-800

Informa Healthcare

Access to resources Recommend Favorite

Deletion of Idiotype (Id)-Specific T Cells in Multiple Myeloma

By Bogen Bjarne   Schenck Karl   Munthe Ludvig A.   Dembic Zlatko  

Acta Oncologica, Vol. 39, Iss. 7, 2000-11 ,pp. : 783-788

Informa Healthcare

Access to resources Recommend Favorite